Saving your money for next purchases
Brentuximab Vedotin for Injection
Brentuximab for injection is an antibody-drug conjugate (ADC) targeting CD30 and is indicated for the treatment of adult patients with the following CD30-positive lymphomas:
Relapsed or refractory systemic anaplastic large cell lymphoma (sALCL);
Relapsed or refractory classical Hodgkin lymphoma (cHL).
Primary cutaneous anaplastic large cell lymphoma (pcALCL) or mycosis fungoides (MF) who have received previous systemic therapy.
Share:
Products
Our offers
Delivery – when you want and anywhere
A huge selection of best products
Health Classification
Let us work together to protect precious health
